4Tissue is pioneering advancements in regenerative medicine through its innovative hydrogel tissue mimic technology, specifically designed for breast reconstruction following cancer treatment. This technology addresses the limitations of traditional methods, such as implants and flap surgeries, by offering a minimally invasive, injectable solution that promotes natural cell regeneration. The hydrogel acts as a nurturing environment for cells, enhancing their survival and supporting the formation of healthy, natural tissue. By utilizing the body’s own materials, 4Tissue's approach minimizes the risks associated with synthetic implants, such as rejection and complications, while also ensuring minimal scarring due to the small-needle injection technique.

The company’s proprietary biocompatible and bioresorbable polymers are versatile and can be tailored for various therapeutic applications. These advanced biomaterials not only improve soft tissue reconstruction but also facilitate the integration of the body’s own fat or stem cells, providing essential nutrients and support for tissue generation. As the hydrogel resorbs, it leaves behind a durable and natural tissue structure, offering a safer and more predictable alternative to conventional breast reconstruction methods. Through its commitment to cutting-edge science and collaboration with experts in the field, 4Tissue aims to significantly enhance patient outcomes in regenerative medicine.

Belgium

4Tissue is an innovation-led research and clinical development organization. Our mission is to redefine the boundaries of tissue reconstruction, regeneration, and anti-aging, utilizing innovative biocompatible and bioresorbable polymers platform The first product, a bioresorbable injectable hydrogel, is focused on a better cell survival and the full regeneration of adipose tissue for breast reconstruction and augmentation applications.

4Tissue

Company Details